Millennium Pharmacon (Indonesia) Buy Hold or Sell Recommendation

SDPC Stock  IDR 144.00  1.00  0.69%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Millennium Pharmacon International is 'Strong Sell'. Macroaxis provides Millennium Pharmacon buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SDPC positions. The advice algorithm takes into account all of Millennium Pharmacon's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Osisko Gold Ro's buy or sell advice are summarized below:
Real Value
125.16
Hype Value
144
Market Value
144
Naive Value
143.52
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Millennium Pharmacon International given historical horizon and risk tolerance towards Millennium Pharmacon. When Macroaxis issues a 'buy' or 'sell' recommendation for Millennium Pharmacon International, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Millennium Pharmacon Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Millennium and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute Millennium Pharmacon Buy or Sell Advice

The Millennium recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Millennium Pharmacon International. Macroaxis does not own or have any residual interests in Millennium Pharmacon International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Millennium Pharmacon's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Millennium PharmaconBuy Millennium Pharmacon
Strong Sell

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Millennium Pharmacon International has a Mean Deviation of 1.21, Standard Deviation of 1.79 and Variance of 3.19
Macroaxis provides trade recommendations on Millennium Pharmacon to complement and cross-verify current analyst consensus on Millennium Pharmacon. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Millennium Pharmacon is not overpriced, please verify all Millennium Pharmacon International fundamentals, including its shares owned by institutions, price to book, revenue, as well as the relationship between the price to earning and price to sales .

Millennium Pharmacon Trading Alerts and Improvement Suggestions

Millennium Pharmacon generated a negative expected return over the last 90 days
Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24.
Roughly 88.0% of the company outstanding shares are owned by corporate insiders

Millennium Pharmacon Returns Distribution Density

The distribution of Millennium Pharmacon's historical returns is an attempt to chart the uncertainty of Millennium Pharmacon's future price movements. The chart of the probability distribution of Millennium Pharmacon stock daily returns describes the distribution of returns around its average expected value. We use Millennium Pharmacon International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Millennium Pharmacon returns is essential to provide solid investment advice for Millennium Pharmacon.
Mean Return
-0.08
Value At Risk
-2.05
Potential Upside
2.56
Standard Deviation
1.79
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Millennium Pharmacon historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Millennium Pharmacon Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Millennium Pharmacon or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Millennium Pharmacon's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Millennium stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.07
β
Beta against NYSE Composite-0.19
σ
Overall volatility
1.39
Ir
Information ratio -0.13

Millennium Pharmacon Volatility Alert

Millennium Pharmacon International exhibits very low volatility with skewness of 2.22 and kurtosis of 9.17. However, we advise investors to further study Millennium Pharmacon International technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Millennium Pharmacon's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Millennium Pharmacon's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Millennium Pharmacon Fundamentals Vs Peers

Comparing Millennium Pharmacon's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Millennium Pharmacon's direct or indirect competition across all of the common fundamentals between Millennium Pharmacon and the related equities. This way, we can detect undervalued stocks with similar characteristics as Millennium Pharmacon or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Millennium Pharmacon's fundamental indicators could also be used in its relative valuation, which is a method of valuing Millennium Pharmacon by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Millennium Pharmacon to competition
FundamentalsMillennium PharmaconPeer Average
Return On Equity0.0938-0.31
Return On Asset0.0342-0.14
Profit Margin0.01 %(1.27) %
Operating Margin0.02 %(5.51) %
Current Valuation828.27 B16.62 B
Shares Outstanding1.27 B571.82 M
Shares Owned By Insiders87.94 %10.09 %
Shares Owned By Institutions3.35 %39.21 %
Price To Earning9.31 X28.72 X
Price To Book1.16 X9.51 X
Price To Sales0.10 X11.42 X
Revenue2.99 T9.43 B
Gross Profit237.04 B27.38 B
EBITDA73.6 B3.9 B
Net Income9.57 B570.98 M
Cash And Equivalents43.62 B2.7 B
Cash Per Share34.24 X5.01 X
Total Debt1.8 B5.32 B
Debt To Equity257.80 %48.70 %
Current Ratio1.15 X2.16 X
Book Value Per Share202.66 X1.93 K
Cash Flow From Operations(18.18 B)971.22 M
Earnings Per Share19.19 X3.12 X
Number Of Employees1.09 K18.84 K
Beta0.75-0.15
Market Capitalization440.8 B19.03 B
Total Asset1.21 T29.47 B
Annual Yield0 %
Net Asset1.21 T
Last Dividend Paid1.0

Millennium Pharmacon Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Millennium . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Millennium Pharmacon Buy or Sell Advice

When is the right time to buy or sell Millennium Pharmacon International? Buying financial instruments such as Millennium Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Millennium Pharmacon in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ESG Investing Thematic Idea Now

ESG Investing
ESG Investing Theme
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
View All  Next Launch
Check out Millennium Pharmacon Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.